Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
The U.S. Supreme Court's ruling Monday giving the U.S. Patent and Trademark Office director the right to review Patent Trial and Appeal Board decisions will require vital guidance from the agency on the front end, even if attorneys say it won't ultimately lead to a dramatic change in proceedings.
A former OptumRx executive testified Monday during a California federal jury trial over class overcharge claims against CVS Pharmacy Inc. that the pharmacy benefit manager's contract with CVS didn't require CVS to report discounted drugs prices under its Health Savings Pass program, which customers allege led to higher insurance copays.
A Georgia-based dietary supplement company and its owner have pled guilty in Virginia federal court to a felony charge for distributing anabolic steroids and steroid-like drugs without U.S. Food and Drug Administration approval.
The U.S. Supreme Court on Monday theoretically gave the next director of the U.S. Patent and Trademark Office expansive new power to determine the validity of patents, but practical and political considerations will likely limit the eventual nominee's ability to wield it, attorneys say.
A D.C. judge has declined to throw out Walgreens' suit accusing Crowell & Moring LLP of breach of fiduciary duty, finding that the pharmacy has adequately alleged that the firm represented Humana in litigation against it after advising Walgreens on the same drug membership program.